Myda Advisors LLC Viking Therapeutics, Inc. Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$7.67 - $10.63 $383,500 - $531,500	-50,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$7.58 - $9.94 $265,300 - $347,900	35,000 Added 233.33%	50,000 $497,000
Q4 2018 Feb 12, 2019	BUY	$7.16 - $16.21 $28,640 - $64,840	4,000 Added 36.36%	15,000 $115,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $106,699 - $216,149	11,000 New	11,000 $192,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.96B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.